These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 11534036)

  • 1. Interaction of different hemoglobinopathies in Eastern India with a view to establish genotype-phenotype correlation.
    Das SK; De M; Bhattacharya DK; Sengupta B; Das N; Talukder G
    Am J Hum Biol; 2000 Jul; 12(4):454-459. PubMed ID: 11534036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hemoglobinopathies in Tunisia. An updated review of the epidemiologic and molecular data].
    Fattoum S
    Tunis Med; 2006 Nov; 84(11):687-96. PubMed ID: 17294892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alport syndrome. Molecular genetic aspects.
    Hertz JM
    Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haplotypes linked to three rare beta-thalassemia mutations, originally reported in Tunisia.
    Bibi A; Messaoud T; Fattoum S
    Hemoglobin; 2006; 30(2):175-81. PubMed ID: 16798642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spectrum of beta-thalassemia mutations and their association with allelic sequence polymorphisms at the beta-globin gene cluster in an Eastern Indian population.
    Kukreti R; Dash D; E VK; Chakravarty S; Das SK; De M; Talukder G
    Am J Hematol; 2002 Aug; 70(4):269-77. PubMed ID: 12210807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spectrum of beta-globin gene mutations among thalassemia patients in the West Bank region of Palestine.
    Darwish HM; El-Khatib FF; Ayesh S
    Hemoglobin; 2005; 29(2):119-32. PubMed ID: 15921164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of beta-Thalassemia mutations using the polymerase chain reaction-amplification refractory mutation system and direct DNA sequencing techniques in a group of Egyptian Thalassemia patients.
    El-Gawhary S; El-Shafie S; Niazi M; Aziz M; El-Beshlawy A
    Hemoglobin; 2007; 31(1):63-9. PubMed ID: 17365006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of beta globin gene mutations on the clinical phenotype of beta thalassemia in India.
    Colah R; Nadkarni A; Gorakshakar A; Phanasgaonkar S; Surve R; Subramaniam PG; Bondge N; Pujari K; Ghosh K; Mohanty D
    Blood Cells Mol Dis; 2004; 33(2):153-7. PubMed ID: 15315795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diversity of the 5' beta-globin haplotype of four beta-thalassemia mutations in the Mexican population.
    Morales KR; Magaña MT; Ibarra B; Perea FJ
    Hemoglobin; 2009; 33(1):66-71. PubMed ID: 19205976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Origin of the frameshift codons 41/42 (-TCTT) mutation in the first cases described in the Spanish population.
    Ropero P; de la Iglesia S; Calvo-Villas JM; González FA; Paúl R; Villegas A
    Hemoglobin; 2008; 32(5):513-9. PubMed ID: 18932079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in the epidemiology of thalassemia in North America: a new minority disease.
    Vichinsky EP; MacKlin EA; Waye JS; Lorey F; Olivieri NF
    Pediatrics; 2005 Dec; 116(6):e818-25. PubMed ID: 16291734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of hemoglobin E and several forms of alpha-thalassemia in Cambodian families.
    Fucharoen S; Sanchaisuriya K; Fucharoen G; Panyasai S; Devenish R; Luy L
    Haematologica; 2003 Oct; 88(10):1092-8. PubMed ID: 14555303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Profile of beta-thalassemia in eastern India and its prenatal diagnosis.
    Bandyopadhyay A; Bandyopadhyay S; Basak J; Mondal BC; Sarkar AA; Majumdar S; Das MK; Chandra S; Mukhopadhyay A; Sanghamita M; Ghosh K; Dasgupta UB
    Prenat Diagn; 2004 Dec; 24(12):992-6. PubMed ID: 15614841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multicenter study of the molecular basis of thalassemia intermedia in different ethnic populations.
    Verma IC; Kleanthous M; Saxena R; Fucharoen S; Winichagoon P; Raizuddin S; Khan SN; Akbari MT; Izadyar M; Kotea N; Old JM; Ioannou PA; Khan B
    Hemoglobin; 2007; 31(4):439-52. PubMed ID: 17994378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spectrum of hemoglobinopathies in the state of Orissa, India: a ten years cohort study.
    Balgir RS
    J Assoc Physicians India; 2005 Dec; 53():1021-6. PubMed ID: 16572956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The molecular pathology of beta-thalassemia in Turkey: the Boğaziçi university experience.
    Basak AN
    Hemoglobin; 2007; 31(2):233-41. PubMed ID: 17486506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regional heterogeneity of beta-thalassemia mutations in the multi ethnic Indian population.
    Colah R; Gorakshakar A; Nadkarni A; Phanasgaonkar S; Surve R; Sawant P; Mohanty D; Ghosh K
    Blood Cells Mol Dis; 2009; 42(3):241-6. PubMed ID: 19254853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
    Jensen HK
    Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Four mutations (three novel, one founder) in TACSTD2 among Iranian GDLD patients.
    Alavi A; Elahi E; Tehrani MH; Amoli FA; Javadi MA; Rafati N; Chiani M; Banihosseini SS; Bayat B; Kalhor R; Amini SS
    Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4490-7. PubMed ID: 17898270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diagnostic strategy of beta-thalassemic mutation in a Tunisian family, application in prenatal diagnosis].
    Khelil AH; Laradi S; Ferchichi S; Carion N; Béjaoui M; Saad A; Chaieb A; Miled A; Ben Chibani J; Perrin P
    Ann Biol Clin (Paris); 2003; 61(2):229-33. PubMed ID: 12702481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.